DD131020A5 - Verfahren zur herstellung neuer derivate von 3-alkyl-1,9-dihydroxy-und-1-hydroxy-9-keto-dibenzo(b,d)-pyranen - Google Patents

Verfahren zur herstellung neuer derivate von 3-alkyl-1,9-dihydroxy-und-1-hydroxy-9-keto-dibenzo(b,d)-pyranen

Info

Publication number
DD131020A5
DD131020A5 DD7700199391A DD19939177A DD131020A5 DD 131020 A5 DD131020 A5 DD 131020A5 DD 7700199391 A DD7700199391 A DD 7700199391A DD 19939177 A DD19939177 A DD 19939177A DD 131020 A5 DD131020 A5 DD 131020A5
Authority
DD
German Democratic Republic
Prior art keywords
pyranes
dibenzo
keto
dihydroxy
hydroxy
Prior art date
Application number
DD7700199391A
Other languages
German (de)
English (en)
Inventor
David S Fukuda
Bernard J Abbott
Robert A Archer
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DD131020A5 publication Critical patent/DD131020A5/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/832—Bacillus
    • Y10S435/834—Bacillus cereus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/886—Streptomyces
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/911—Microorganisms using fungi
    • Y10S435/931—Mucor

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
DD7700199391A 1976-06-09 1977-06-09 Verfahren zur herstellung neuer derivate von 3-alkyl-1,9-dihydroxy-und-1-hydroxy-9-keto-dibenzo(b,d)-pyranen DD131020A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/694,512 US4064009A (en) 1976-06-09 1976-06-09 Novel 3-(oxygenated alkyl)-1,9-dihydroxy and 1-hydroxy-9-keto dibenzo[b,d]py

Publications (1)

Publication Number Publication Date
DD131020A5 true DD131020A5 (de) 1978-05-24

Family

ID=24789127

Family Applications (1)

Application Number Title Priority Date Filing Date
DD7700199391A DD131020A5 (de) 1976-06-09 1977-06-09 Verfahren zur herstellung neuer derivate von 3-alkyl-1,9-dihydroxy-und-1-hydroxy-9-keto-dibenzo(b,d)-pyranen

Country Status (28)

Country Link
US (2) US4064009A (fr)
JP (1) JPS52151173A (fr)
AR (1) AR214636A1 (fr)
AT (1) AT356049B (fr)
AU (1) AU508677B2 (fr)
BE (1) BE855347A (fr)
BG (1) BG30773A3 (fr)
CA (1) CA1097237A (fr)
CH (1) CH640000A5 (fr)
CS (1) CS189599B2 (fr)
DD (1) DD131020A5 (fr)
DE (1) DE2725713A1 (fr)
DK (1) DK144971C (fr)
ES (1) ES459644A1 (fr)
FR (1) FR2354326A1 (fr)
GB (1) GB1583062A (fr)
GR (1) GR66428B (fr)
HU (1) HU174139B (fr)
IE (1) IE44992B1 (fr)
IL (1) IL52248A (fr)
NL (1) NL7706276A (fr)
NZ (1) NZ184332A (fr)
PH (1) PH12513A (fr)
PL (1) PL106942B1 (fr)
PT (1) PT66627B (fr)
RO (1) RO73175A (fr)
SE (1) SE413779B (fr)
ZA (1) ZA773467B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4948732A (en) * 1989-02-10 1990-08-14 Schering Corporation Microbiological chiral reduction of carbonyl groups
DE4034218A1 (de) * 1990-10-27 1992-04-30 Merck Patent Gmbh Verfahren zur herstellung von carebastin
US6566560B2 (en) 1999-03-22 2003-05-20 Immugen Pharmaceuticals, Inc. Resorcinolic compounds
HUP0203437A3 (en) 1999-03-22 2003-07-28 Immugen Pharmaceuticals Inc So Use of resorcinol derivatives for producing pharmaceutical compositions for treatment of immune diseases
AU2001296402A1 (en) * 2000-09-28 2002-04-08 Immugen Pharmaceuticals, Inc. Methods and compounds for inhibiting eicosanoid metabolism and platelet aggregation
AU2002213429A1 (en) * 2000-09-28 2002-04-08 Immugen Pharmaceuticals, Inc. Antiviral methods and compounds
US20030232101A1 (en) * 2002-03-18 2003-12-18 Immugen Pharmaceuticals, Inc. Topical formulations of resorcinols and cannibinoids and methods of use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3822188A (en) * 1972-10-19 1974-07-02 Abbott Lab Method of producing 1,4'-dihydroxy-3-n-pentyl-6,6,9-trimethyl-6a,7,10,10a-tetra-hydrodibenzo(b,d)pyran
DE2335136A1 (de) * 1973-07-06 1975-01-16 Schering Ag 7-hydroxy-delta hoch 8-tetrahydrocannabinole

Also Published As

Publication number Publication date
PT66627B (en) 1978-11-09
PL198731A1 (pl) 1978-04-10
ZA773467B (en) 1979-01-31
IL52248A (en) 1980-09-16
GB1583062A (en) 1981-01-21
DK247077A (da) 1977-12-10
AT356049B (de) 1980-04-10
FR2354326A1 (fr) 1978-01-06
CH640000A5 (de) 1983-12-15
BG30773A3 (en) 1981-08-14
CA1097237A (fr) 1981-03-10
SE7706692L (sv) 1977-12-10
SE413779B (sv) 1980-06-23
PH12513A (en) 1979-04-20
IL52248A0 (en) 1977-08-31
PL106942B1 (pl) 1980-01-31
RO73175A (fr) 1981-11-24
NL7706276A (nl) 1977-12-13
ATA402377A (de) 1979-09-15
HU174139B (hu) 1979-11-28
JPS52151173A (en) 1977-12-15
IE44992L (en) 1977-12-09
DK144971B (da) 1982-07-19
DE2725713A1 (de) 1977-12-22
BE855347A (fr) 1977-12-05
US4104282A (en) 1978-08-01
PT66627A (en) 1977-07-01
ES459644A1 (es) 1978-04-01
AR214636A1 (es) 1979-07-13
FR2354326B1 (fr) 1980-02-08
CS189599B2 (en) 1979-04-30
AU2593577A (en) 1978-12-14
DK144971C (da) 1982-12-13
US4064009A (en) 1977-12-20
NZ184332A (en) 1978-09-20
IE44992B1 (en) 1982-06-02
GR66428B (fr) 1981-03-23
AU508677B2 (en) 1980-03-27

Similar Documents

Publication Publication Date Title
AT363196B (de) Verfahren zur herstellung von androstan-17-on-derivaten
AT362364B (de) Verfahren zur herstellung neuer phenylimi- dazolidinonderivate
AT367092B (de) Verfahren zur herstellung von androsten-3,17-dion-derivaten
AT352120B (de) Verfahren zur herstellung von neuen benzoxocin- derivaten
DD131020A5 (de) Verfahren zur herstellung neuer derivate von 3-alkyl-1,9-dihydroxy-und-1-hydroxy-9-keto-dibenzo(b,d)-pyranen
AT345780B (de) Verfahren zur herstellung von neuem 3,7- dimethyl-3-hydroxyoctannitril
AT356655B (de) Verfahren zur herstellung von neuen benzodia- zepinderivaten
AT353268B (de) Verfahren zur herstellung von 6a,10a-cis- hexahydrodibenzopyranonen
AT347937B (de) Verfahren zur herstellung von neuen sulfonylbenzimidazol-derivaten
AT365601B (de) Verfahren zur herstellung neuer derivate von 4-
AT358055B (de) Verfahren zur herstellung von 2-chlor-4,6-bis- -alkylamino-s-triazinen
AT353986B (de) Verfahren zur herstellung neuer quartaerer derivate von sandwicin
AT361928B (de) Verfahren zur herstellung von neuen chinolonderivaten
ATA966976A (de) Verfahren zur herstellung von 2-aminoindanderivaten
AT367094B (de) Verfahren zur herstellung von 4-androsten-3,17dion-derivaten
AT357516B (de) Verfahren zur herstellung neuer 2,3-dihydro- benzofuranon-2-derivate
DD129335A5 (de) Verfahren zur herstellung von androstan-3,17-dion-derivaten
AT364840B (de) Verfahren zur herstellung von 1,3-dimethyl-2-methylimino-4-imidazolidinonderivaten
AT362349B (de) Verfahren zur herstellung von neuen 3-amino-2- -hydroxypropoxyaryl-derivaten
AT382148B (de) Verfahren zur herstellung von chinazolinonderivaten
AT353790B (de) Verfahren zur herstellung von indolderivaten
ATA378379A (de) Verfahren zur herstellung von nitroalkanolderivaten
ATA448480A (de) Verfahren zur herstellung von 1,3-dimethyl-2- methylimino-4-imidazolidinonderivaten
ATA32881A (de) Verfahren zur herstellung neuer derivate von
AT352733B (de) Verfahren zur herstellung neuer thieno-4,1- oxazepine